VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
SGRY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
SGRYSurgery Partners, Inc.
$14.56$1.9B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksSGRYQuarterly Financials

Surgery Partners, Inc. (SGRY) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

Surgery Partners, Inc. (SGRY) quarterly income statement — complete revenue, gross profit & net income history

Income StatementBalance SheetCash FlowRatios

SGRY Income Statement

Quarterly statement

SGRY Income Statement

Surgery Partners, Inc. (SGRY) annual income statement — 13-year revenue, gross profit & net income history

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Sales/Revenue848.9M810.9M885M821.5M826.2M776M864.4M770.4M762.1M717.4M735.4M674.1M667.6M666.2M707.1M620.6M615.4M596.2M610.2M559.2M
Revenue Growth %2.75%4.5%2.38%6.63%8.41%8.17%17.54%14.29%14.16%7.69%4%8.62%8.48%11.74%15.88%10.98%13.27%16.35%11.29%12.72%
Cost of Goods Sold658.7M689.2M672.8M626.2M630.6M614.1M630.8M592.9M582.9M562.1M541.8M508.3M513.5M532.2M522.8M489.4M480.8M471.4M463.1M436.7M
COGS % of Revenue77.59%84.99%76.02%76.23%76.33%79.14%72.98%76.96%76.49%78.35%73.67%75.4%76.92%79.89%73.94%78.86%78.13%79.07%75.89%78.09%
Gross Profit190.2M121.7M212.2M195.3M195.6M161.9M233.6M177.5M179.2M155.3M193.6M165.8M154.1M134M184.3M131.2M134.6M124.8M147.1M122.5M
Gross Margin %22.41%15.01%23.98%23.77%23.67%20.86%27.02%23.04%23.51%21.65%26.33%24.6%23.08%20.11%26.06%21.14%21.87%20.93%24.11%21.91%
Gross Profit Growth %-2.76%-24.83%-9.16%10.03%9.15%4.25%20.66%7.06%16.29%15.9%5.05%26.37%14.49%7.37%25.29%7.1%13.78%20.58%8.64%7.27%
Operating Expenses88.1M39.3M102M89.6M83.9M100M106.5M116.6M94.4M79.3M92.2M83.2M56.5M87.6M90.1M57.1M58.1M24.4M32.3M58.9M
OpEx % of Revenue10.38%4.85%11.53%10.91%10.15%12.89%12.32%15.14%12.39%11.05%12.54%12.34%8.46%13.15%12.74%9.2%9.44%4.09%5.29%10.53%
Selling, General & Admin36.3M140.6M126.8M323.8M36.1M36M36M29.2M40.3M33.2M20.9M36.8M31.2M32M28.7M17.9M26.1M29.5M27.2M25.5M
SG&A % of Revenue4.28%17.34%14.33%39.42%4.37%4.64%4.16%3.79%5.29%4.63%2.84%5.46%4.67%4.8%4.06%2.88%4.24%4.95%4.46%4.56%
Research & Development00000000000000000000
R&D % of Revenue--------------------
Other Operating Expenses1000K-1000K-1000K-1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K-1000K1000K1000K
Operating Income102.1M82.4M110.2M105.7M111.7M61.9M127.1M60.9M84.8M76M101.4M82.6M97.6M46.4M94.2M74.1M76.5M100.4M114.8M63.6M
Operating Margin %12.03%10.16%12.45%12.87%13.52%7.98%14.7%7.9%11.13%10.59%13.79%12.25%14.62%6.96%13.32%11.94%12.43%16.84%18.81%11.37%
Operating Income Growth %-8.59%33.12%-13.3%73.56%31.72%-18.55%25.35%-26.27%-13.11%63.79%7.64%11.47%27.58%-53.78%-17.94%16.51%28.57%56.14%19.21%243.78%
EBITDA141.4M120.9M170.1M145.2M152M98.2M161M111.1M119.6M109.7M132.5M111.5M122M80.1M123.8M103.9M104.5M127.8M137.5M88.8M
EBITDA Margin %16.66%14.91%19.22%17.68%18.4%12.65%18.63%14.42%15.69%15.29%18.02%16.54%18.27%12.02%17.51%16.74%16.98%21.44%22.53%15.88%
EBITDA Growth %-6.97%23.12%5.65%30.69%27.09%-10.48%21.51%-0.36%-1.97%36.95%7.03%7.31%16.75%-37.32%-9.96%17%23.38%42%12.89%108.45%
D&A (Non-Cash Add-back)39.3M38.5M59.9M39.5M40.3M36.3M33.9M50.2M34.8M33.7M31.1M28.9M24.4M33.7M29.6M29.8M28M27.4M22.7M25.2M
EBIT102.1M67.2M235.2M365.9M111.7M61.9M127.1M60.9M84.8M76M101.4M82.6M97.6M46.4M94.2M74.1M76.5M100.4M114.8M63.6M
Net Interest Income-69.8M-70.5M-192.6M-335.1M-67.9M-62.2M-52.9M-50M-51.5M-47.3M-48.7M-49.8M-47.7M-46.8M-61M-60.7M-56.9M-56.3M-60.1M-54.2M
Interest Income00000000000000000000
Interest Expense69.8M70.5M192.6M335.1M67.9M62.2M52.9M50M51.5M47.3M48.7M49.8M47.7M46.8M61M60.7M56.9M56.3M60.1M54.2M
Other Income/Expense-69.8M-85.7M-67.6M-74.9M-67.9M-62.2M-52.9M-50M-51.5M-47.3M-48.7M-49.8M-47.7M-46.8M-61M-60.7M-56.9M-56.3M-60.1M-54.2M
Pretax Income32.3M-3.3M42.6M30.8M43.8M-300K74.2M10.9M33.3M28.7M52.7M32.8M49.9M-400K33.2M13.4M19.6M44.1M54.7M9.4M
Pretax Margin %3.8%-0.41%4.81%3.75%5.3%-0.04%8.58%1.41%4.37%4%7.17%4.87%7.47%-0.06%4.7%2.16%3.18%7.4%8.96%1.68%
Income Tax2.6M-1.2M13.6M5.5M-1.1M0120.8M4.5M4.9M4.4M6M3.1M-7.8M-1.6M9.9M7.8M4.3M1.3M11.8M1.2M
Effective Tax Rate %8.05%36.36%31.92%17.86%-2.51%0%162.8%41.28%14.71%15.33%11.39%9.45%-15.63%400%29.82%58.21%21.94%2.95%21.57%12.77%
Net Income-15M-35.9M-15M-22.7M-2.5M-37.7M-108.5M-31.7M-15.5M-12.4M-1M-4.9M18.9M-24.9M-23.4M-25M-18.4M12.2M-100K-22.9M
Net Margin %-1.77%-4.43%-1.69%-2.76%-0.3%-4.86%-12.55%-4.11%-2.03%-1.73%-0.14%-0.73%2.83%-3.74%-3.31%-4.03%-2.99%2.05%-0.02%-4.1%
Net Income Growth %-500%4.77%86.18%28.39%83.87%-204.03%-10750%-546.94%-182.01%50.2%95.73%80.4%202.72%-304.1%-23300%-9.17%31.6%158.1%-101.82%62.82%
Net Income (Continuing)29.7M-2.1M29M25.3M44.9M-300K-46.6M6.4M28.4M24.3M46.7M29.7M57.7M1.2M23.3M5.6M15.3M42.8M42.9M8.2M
Discontinued Operations00000000000000000000
Minority Interest1.43B1.79B1.81B1.82B1.83B1.85B1.85B1.65B1.67B1.39B1.37B1.31B1.29B1.33B1.28B1.27B1.23B1.19B1.21B1.11B
EPS (Diluted)-0.12-0.28-0.11-0.18-0.02-0.30-0.86-0.25-0.12-0.10-0.010.290.150.010.23-0.280.170.47-0.00-0.28
EPS Growth %-509.14%6.67%87.21%28%83.58%-204.88%--186.21%-180%--103.48%203.57%-11.76%-97.96%-0%143.59%223.68%98.8%77.78%
EPS (Basic)-0.12-0.28-0.11-0.18-0.02-0.30-0.86-0.25-0.12-0.10-0.010.290.150.010.23-0.280.170.49-0.00-0.28
Diluted Shares Outstanding128.82M128.37M127.21M126.93M126.98M126.6M126.21M126.17M126.13M125.97M125.77M125.75M127.37M125.21M101.89M88.91M88.9M90.27M84.52M80.73M
Basic Shares Outstanding128.82M128.37M127.21M126.93M126.98M126.6M126.21M126.17M126.13M125.97M125.77M125.75M125.72M125.21M101.89M88.91M87.62M88M84.52M80.73M
Dividend Payout Ratio--------------------